[tdw28210]

This is pretty significant:

• Johnson & Johnson said Monday human testing of its experimental vaccine for the coronavirus would begin by September and that it could be available for emergency use authorization in early 2021.
• Shares of Johnson & Johnson rose more than 5% in premarket trading.
• The company said it is also increasing its manufacturing capacity with a new site in the U.S. and additions to previously existing sites in other countries to produce and distribute the potential vaccine quickly.

BUT...CNBC is saying they may be selling this AT COST, so not necessarily accretive to earnings. I'll go buy some band-aids to show my support.